3Michelson AD,Frelinger AL 3rd,Furman MI.Current options in platelet function testing[J].Am J Cardio1,2006,98(10A):4N-10N.
4Walter DH,Fichtlsche S,Britten MB,et al.Benefits of immediate initiation of stattin the rapy following successful coronary stent implantation in patients with stable and unstable angina pectoris and Q-wave acute myocardial infarction[J].Am J Cardionl,2002,89:1-6.
5Schwartz GG,Olsson AG,Ezekowitz MD,et al.Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes the MIRACL study:a randomized controlled trial[J].JA-MA,2001,285:1711-1718.
6Sabatine MS,Cannon CP,Gibson GM,et al.Effect of clopidogrel pretreatment before percutaneous coronary intervention in patients with ST-Elevation myocardial infarction treated with fibrinolytics the PCI-CLARITY study[J].JAMA,2005,294:1224-1232.
7Sidney C,Smith SC Jr,Ted E,et al.ACC/AHA/SCA 2005 guideline update for percutaneous coronary intervention:a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCA Ⅰ Writing Committee to Update the 2001 Guidelines for Percutaneous Coronary Intervention)[J].J Am Coll Cardiol,2006,47:1-121.
8Grines CL,Bonow RO,Casey DE.Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents[J].Circulation,2007,115:813-818.
